Glucose output from perfused livers of 48 h-starved rats was stimulated by phenylephrine (2pM) when lactate, pyruvate, alanine, glycerol, sorbitol, dihydroxyacetone or fructose were used as gluconeogenic precursors. Phenylephrine-induced increases in glucose output were immediately preceded by a transient efflux of Ca2+ and a sustained increase in oxygen uptake. Phenylephrine decreased the perfusate [lactatel/[pyruvatel ratio when sorbitol or glycerol was present, but increased the ratio when alanine, dihydroxyacetone or fructose was present. Phenylephrine induced a rapid increase in the perfusate [,8-hydroxybutyratel responses to phenylephrine infusion were diminished after depletion of the hepatic a-agonist-sensitive pool of Ca2+ and returned toward maximal responses after Ca2+ re-addition. Phenylephrine-induced increases in glucose output from lactate, sorbitol and glycerol were inhibited by the transaminase inhibitor amino-oxyacetate by 95%, 75% and 66% respectively. Data presented suggest that the mobilization of an intracellular pool of Ca2+ is involved in the activation of gluconeogenesis by a-adrenergic agonists in perfused rat liver. a-Adrenergic activation of gluconeogenesis is apparently accompanied by increases in fatty acid oxidation and tricarboxylic acid-cycle flux. An enhanced transfer of reducing equivalents from the cytoplasmic to the mitochondrial compartment may also be involved in the stimulation of glucose output from the relatively reduced substrates glycerol and sorbitol and may arise principally from an increased flux through the malate-aspartate shuttle.
Ca2+ ions appear to be involved in the mechanism of action of a-adrenergic agonists in liver in both the fed and starved states (for reviews see: Exton, 1981; Williamson et al., 1981; Taylor et al., 1983) . Although it is generally agreed that a-adrenergic agonists enhance glycogenolysis through a Ca2+-dependent activation of phosphorylase b kinase, such clearly defined regulatory site(s) have not been elucidated for the stimulation of the gluconeogenic pathway by these agonists. Proposed sites of action of a-adrenergic agonists include pyruvate carboxylase Williamson et al., 1981) , phosphoenolpyruvate carboxykinase (Merryfield & Lardy, 1982) and pyruvate kinase (Garrison et al., , 1981 . It has also been suggested that these agonists may stimulate gluconeogenesis from reduced substrates such as glycerol Vol. 212 and sorbitol in hepatocytes, by promoting the exchange of reducing equivalents from the cytoplasmic to the mitochondrial compartment (Kneer et al., 1979; Yip & Lardy, 1981) . A Ca2+-dependent activation of the mitochondrial glycerol phosphate dehydrogenase was purported to play a major role in this exchange mechanism (Yip & Lardy, 1981) . However, a-adrenergic agonists have also been reported to stimulate gluconeogenesis by a mechanism apparently independent of Ca2+ (Kneer et al., 1979 ).
Previously we described a method for depleting the a-adrenergic-sensitive Ca2+ pool in the perfused rat liver (Reinhart et al., 1982a) . In the present study this technique is employed to examine further the role of Ca2+ in the stimulation of gluconeogenesis by a-adrenergic agonists in the perfused liver of starved rats. This study provides insights into the general role of Ca2+ and examines the possible role of mitochondrial respiration and transfer of reducing equivalents across the mitochondrial inner membrane.
Experimental Animals andperfusions
Wistar-strain albino rats (200-280g body wt.) were starved for 48 h before use. Rats were anaesthetized with sodium pentobarbitone (50mg/ kg), and the livers perfused with Krebs-Henseleit (1932) bicarbonate medium equilibrated wtih 02/ CO2 (19:1) and modified to contain 1.3 mm added CaCl2 unless otherwise indicated. All other perfusion details were as described previously (Reinhart et al., 1982a) .
Perfusate Ca2+ and oxygen determinations
Perfusate Ca2+ and oxygen concentrations were continuously monitored wtih a Radiometer F2112 Ca2+_selective electrode and Clark-type oxygen elctrode, respectively, as detailed by Reinhart et al. (1982a) . Lag times for Ca2+ and oxygen responses were determined as described previously (Reinhart etal., 1982b [3Hlinulin, both as described by Reinhart et al. (1982b) . In some experiments, larger volumes of perfusate (7ml) were collected in graduated centrifuge tubes, centrifuged to remove contaminating erythrocytes, and the supernatants (6 ml) mixed with 0. 
Results
Although the glycogen contents in livers of starved rats are reported to be low (Exton & Park, 1967; Hems & Whitton, 1973) and therefore unlikely to contribute significantly to glucose output by the liver, it was important to establish this point at the outset of the present experiments. Use was made of the finding that the transaminase inhibitor amino-oxyacetate, which blocks the malate-aspartate shuttle (Borst, 1963) , inhibits gluconeogenesis from lactate (Arinze et al., 1973; Rognstad, 1980) . Data in Fig. 1 show that the presence of 0.2 mM-amino-oxyacetate essentially abolished the increase in glucose output induced by lactate infusion in livers of 48h-starved rats. In addition, glucose output in the absence of added lactate was very low (cf. that observed in the perfused liver of fed rats; Reinhart et al., 1982a,b) , and was also decreased by approx. 40% by amino-oxyacetate. Moreover, phenylephrine-induced increases in glucose output in either the presence or the absence of lactate were largely prevented by the transaminase inhibitor. The maximal rate of glucose output induced by phenylephrine in the absence of lactate was only 5-10% of that observed in the fed rat (see Reinhart et al., 1982b) , and substantial increases in glucose output were only induced by phenylephrine in the presence of lactate. In other control experiments amino-oxyacetate was shown to have little effect on basal oxygen consumption by the liver and to inhibit only slightly phenylephrine-induced in- We would thus conclude that the substrate-and hormone-induced increase in glucose output observed in Fig. 1 No. of exposures to phenylephrine Fig. 3 . Dependence on Ca2+ ofphenylephrine-induced increases in Ca2+ efflux, oxygen uptake and glucose output Livers were initially perfused for 15 min as described in Fig. 2 . Phenylephrine (2,UM) was then infused in five pulses each of 4 min duration and at 4min intervals except the last, which was given 8 min after the fourth pulse. In some experiments (hatched columns) the 1.3 mM-CaCl2 present in the perfusion medium (administered by infusion syringe) was removed 4min before the commencement of the phenylephrine infusions. In those experiments, 1.3 mM-CaCl2 was re-administered for 2 min, 6 min before the fifth phenylephrine infusion. All other experiments were performed with 1.3 mM-CaCl2 present throughout the entire perfusion (open columns). Perfusate Ca2+ (a), oxygen uptake (b) and glucose output (c) were determined as described in the Experimental section and the maximal increase induced by each phenylephrine infusion is shown. Basal values for oxygen uptake and glucose output were 345 + 54pM and 87 + 1 1pM respectively at a perfusate Ca2+ concentration of 1.3mM, and 341 + 5O,UM and 84 + 12puM respectively in experiments where the CaCl2 infusion was terminated and perfusate Ca2+ decreased to approx. 6,UM just before infusion of phenylephrine. These basal values remained essentially unchanged throughout the experimental period. Data shown are the means + S.E.M. for five separate experiments. evident after 9.5 + 0.8, 10.5 + 1.1 and approx. 20s respectively. The increase in Ca2+ efflux was transient, with a maximal increase of 21.7+2.3,UM being attained after 75s of phenylephrine infusion. Ca2+ efflux declined thereafter and reached basal values again by 2.5min (Fig. 2 ). In contrast with the transient effect on Ca2+ efflux, phenylephrineinduced increases in oxygen uptake and glucose output were maintained near maximal values until the a-agonist infusion was discontinued (results not shown). Near-maximal increases in oxygen uptake and glucose output were achieved after 1.5 and 2 min of phenylephrine infusion respectively (Fig. 2) . The responses in terms of Ca2+ efflux and oxygen consumption to phenylephrine seen here are virtually identical with those seen with perfused livers from fed rats (Reinhart et al., 1982a,b) .
The next set of experiments involved utilizing conditions that lead to the depletion of the aadrenergic-agonist-sensitive pool of Ca2+ in the perfused liver of the fed rat and were designed to test the hypothesis that intracellular Ca2+ is essential for a-adrenergic-agonist-induced increases in gluconeogenesis. The procedure involves perfusing the liver without added Ca2+ in the medium and to infuse phenylephrine by repeated pulses (see Fig. 5 of Reinhart et al., 1982a) . As shown in that paper, four such pulses, each of 90 s duration and given at 5 min intervals, were sufficient essentially to deplete the liver of the a-adrenergic-sensitive intracellular Ca2+ pool.
Data in Fig. 3(a) show that when the livers of 48 h-starved rats, perfused with buffer containing no added Ca2+, were given four repeated pulses of phenylephrine, the maximum rate of Ca2+ efflux was decreased from 20,UM to approx. 2pM, reflecting a loss of phenylephrine-sensitive intracellular Ca2 . The response to the fifth pulse, given after a 2 min re-infusion of 1.3 mM-CaCl2 to the liver, was approx. 70% of that which followed the first pulse. A parallel diminution in oxygen uptake and gluconeogenic responses was observed after the loss of intra- Table 1 . Dependence on Ca2+ ofphenylephrine-induced increases in glucose output Livers were initially perfused for 15 min as described in Fig. 2 , except that the gluconeogenic substrates (each at 2.5 mm final concn.) were present as shown. Phenylephrine was administered for 4 min, and after a further 4 min the 1.3 mM-CaCl2 in the perfusion medium (administered by infusion syringe) was removed. The liver was then infused with five successive pulses of phenylephrine (2QM) each of 4min duration as described in Fig. 3 . A 2min pulse of 1.3 mM-CaCl2 was administered 6 min before the final phenylephrine infusion. Samples of perfusate were taken for glucose assay, and maximal increases in glucose output induced by phenylephrine were determined before CaCl2 removal (+ 1.3 mM-Ca2+) during the fourth infusion of the a-agonist in buffer containing no added Ca2+ (Ca2+-depleted) and during the last infusion of phenylephrine, 4min after a 2 min re-administration of 1.3 mM-Ca2+ (Ca2+ re-added). For each substrate the rate of basal glucose output was determined after the initial 15 min perfusion and was essentially unchanged throughout the period of perfusion. Data shown are means ± S.E.M. for at least four separate experiments.
Glucose output (#,M) Table 1 were also obtained with 50nM-adrenaline, 50nM-noradrenaline and 2.5 munits of vasopressin/ml (results not shown). It should be noted that, although glucose output was still enhanced by Vol. 212 adrenaline or noradrenaline at higher concentrations of hormone, oxygen consumption was inhibited at catecholamine concentrations greater than 0.5pum.
Thus, and by analogy with information gained earlier from experiments with fed rats (Reinhart et al., 1982a) Since it has been suggested that a-adrenergic agonists may increase gluconeogenesis from relatively reduced substrates by enhancing the transfer of reducing equivalents from the cytoplasmic to the mitochondrial compartment (Kneer et al., 1979; Yip & Lardy, 1981) (Fig. 4) . The [lactate]/ [pyruvatel ratio was decreased by phenylephrine when the relatively reduced substrates glycerol or sorbitol were employed and the initial ratios were relatively high (Fig. 4) . With all other substrates tested, phenylephrine induced an increase in the Samples of perfusate obtained as in Fig. 4 [If-Hydroxybutyratel/[acetoacetatel ratios were increased by phenylephrine irrespective of the substrate employed (Fig. 5) . The ratio increased within 20-30s of phenylephrine infusion, was near maximal by 90s and decreased slightly thereafter, but was still significantly above initial values at the end of the phenylephrine infusion (6min). Effects similar to those described for phenylephrine in Figs. 4 Effect of agents that alter intracellular redox ratios on glucose output
The transaminase inhibitor, amino-oxyacetate, blocks the mitochondrial malate-aspartate shuttle and thereby diminishes the transfer of reducing equivalents between the cytoplasmic and mitochondrial compartments. Data presented in Fig. 6 and Table 2 indicate that amino-oxyacetate (0.2 mM) inhibits basal glucose output from glycerol and sorbitol by 34% and 55% respectively. Moreover, phenylephrine-induced increases in glucose output from glycerol or sorbitol were inhibited by this agent by, 66% and 75% respectively. Amino-oxyacetate, however, had little effect on either basal or phenylephrine-induced glucose output from fructose or dihydroxyacetone.
Phenazine methosulphate, an agent that rapidly re-oxidizes reduced nicotinamide nucleotides, and dinitrophenol, an uncoupler of oxidative phosphorylation, both increased glucose output from glycerol and sorbitol. With glycerol as substrate, phenazine methosulphate (30,M) and dinitrophenol (25,UM) increased glucose output from 73 + 8 to 1 16 + 13 and 134 + 18,UM (n = 4) respectively. With sorbitol, however, dinitrophenol was much less effective, and variable responses were obtained (average increase of 15%), whereas phenazine methosulphate was still an effective activator (112 + 10 versus 198 + 16,M, n = 4). Phenazine methosulphate and dinitrophenol both inhibited glucose output from fructose or dihydroxyacetone and increased total pyruvate and lactate outputs (results not shown).
Effect of phenylephrine on ketogenesis and oxidation of [1-'4C]octanoate and 2-oxo[1-"4C]glutarate
The rate of oxidation of tracer amounts of [1-14C] octanoate to '4CO2 has been used as a measure of tricarboxylic acid-cycle flux in the perfused rat liver (Soboll et al., 1981) . In the present study, tricarboxylic acid-cycle flux was also monitored by following "4CO2 generation from 2-oxo-[1-14C]glutarate and gave results similar to those obtained with [ 1-14Cloctanoate. Relatively low rates of "4CO2 production were observed in the absence of gluconeogenic substrates when rates of ketone-body output were relatively high (see Table 3 ). For example, rates of octanoate oxidation were increased from a basal value of 0.38 + 0.09 ng-atom/ min (n = 3) to 0.80+ 0.11 or 1.5 +0.20ng-atom/ min (n = 4) on addition of sorbitol or fructose respectively. Rates of ketogenesis were correspondingly decreased on addition of sorbitol or fructose (Table 3) . Table 2 . Effect ofphenylephrine and amino-oxyacetate on glucose output Livers were perfused as described in Fig. 6 The effect of phenylephrine on [1-14C]octanoate oxidation is shown in Fig. 7(a) . A rapid increase in Table 3 . Effect of phenylephrine on total ketone-body output Perfusate samples were taken immediately before and 2min after infusion of phenylephrine (2,pM) as described in Fig. 4 octanoate oxidation was observed within 10-15s of phenylephrine infusion when either fructose or sorbitol was present. Maximal increases were observed between 30 and 60s of a-agonist infusion, and rates of oxidation declined thereafter. Some variability in this latter portion of the phenylephrine response was observed. In some experiments rates of oxidation were maintained at approx. 70% of the maximal value, whereas in others the rate fell to approx. 10-20% above the basal value at the completion of the phenylephrine infusion. Essentially similar data were obtained when [1-14C1-octanoate was replaced with 2-oxo[1-_4Clglutarate (Fig. 7b) Ketone-body output was measured during gluconeogenesis from a range of substrates shown in Table 3 . Phenylephrine induced a rapid increase in ketogenesis, with maximal increases of 40-50% being observed within 2min of a-agonist infusion. In the absence of gluconeogenic substrates, ketonebody output was elevated and phenylephrineinduced increases were not significant under those conditions. Phenylephrine did not affect ketone-body output after livers had been perfused under conditions that deplete the a-agonist-sensitive Ca2+ pool (results not shown).
Discussion
Among the major points revealed in this study of a-agonist-induced gluconeogenesis in the perfused liver of starved rats are (a) the obligatory role of Ca2+ in the gluconeogenic response, (b) the variety of metabolic events seemingly associated with the gluconeogenic response and which are also Ca2+-dependent, and (c) the rapidity with which the responses are seen. Of particular interest in this regard was the observation that ketogenesis and tricarboxylate-cycle activity are each increased by a-agonists concomitant with enhanced rates of gluconeogenesis.
An obligatory role for Ca2+ in a-agonist-induced gluconeogenesis could be deduced from experiments in which the a-agonist-sensitive intracellular pool of Ca2+ was manipulated by the administration of phenylephrine through repeated pulses to the liver perfused with bicarbonate buffer containing no added Ca2+ (Fig. 3 , Table 1 ). In this way it could be shown that the smaller the a-agonist-induced Ca2+ efflux (and presumably the greater the depletion of the a-agonist-sensitive Ca2+ pool), the smaller the gluconeogenic response. It was noteworthy that the Ca2+-dependence of the a-agonist-induced increase in glucose output was observed with all gluconeogenic substrates tested (Table 1 and Fig. 3 ). An additional feature of our experimental approach (Reinhart et al., 1982a) , hitherto apparently not undertaken in studies on gluconeogenesis, was the ability to measure rapid and continuous changes in Ca2+ fluxes across the plasma membrane and in whole-tissue respiration; such respiration is attributable in large part to mitochondria (Reinhart et al., 1982b) . In this way we were able to show that such changes precede phenylephrine-induced increases in glucose output. Indeed the time-course and magnitude of Ca2+ efflux induced by phenylephrine in these perfusions with livers from starved rats were virtually identical with the phenylephrineinduced Ca2+ efflux previously shown to precede glycogenolysis in perfused livers of fed rats (Reinhart et aL, 1982a) . The important conclusion can thus be drawn that such changes in Ca2+ efflux are independent of the nutritional status of the experimental animal. The findings also suggest that altered Ca2+ fluxes may be linked to the initial events in the mechanism of action of a-adrenergic agonists in rat liver.
The important role of Ca2+ in the responses to a-adrenergic agonists in rat liver was further highlighted by the findings that the changes induced by phenylephrine in the redox state of the cytoplasm (Fig. 4) and mitochondria (Fig. 5) , as well as in ketogenesis (Table 3 ) and the oxidation of [1-14Cloctanoate or 2-oxo[1-'4C]glutarate (Fig. 7) , were all considerably diminished after depletion of the a-agonist-sensitive Ca2+ pool. As with gluconeogenesis (Fig. 3, Table 1 ), re-infusion of livers with 1.3 mM-CaCl2 restored all of these responses.
A requirement for Ca2+ in the stimulation of gluconeogenesis by a-adrenergic agonists has been reported previously and a number of possible sites for Ca2+ action have been suggested. Tolbert & Fain (1974) reported a Ca2+-dependent catecholamineinduced increase in glucose output from a range of gluconeogenic substrates with rat hepatocytes. However, in those studies, basal rates of gluconeogenesis were markedly decreased by the omission of Ca2+. This is in contrast with the present study and earlier studies with perfused liver (Friedmann & Rasmussen, 1970; Sugano et al., 1980) or hepatocytes (Kneer et al., 1979) , where Ca2+ omission did not cause appreciable changes in the basal rates of gluconeogenesis. More recently, Garrison et al. ( , 1981 have suggested that a cytoplasmic Ca2+-dependent protein kinase may catalyse the phosphorylation and subsequent inhibition of pyruvate kinase in response to catecholamines. In addition, an activation of phosphoenolpyruvate carboxykinase, indirectly mediated by Ca2+, and involving the release of mitochondrial Fe2+, has been proposed by Merryfield & Lardy (1982) . It has also been argued that Ca2+ may regulate pyruvate carboxylase activity (Williamson et al., 1981) .
A Ca2+_sensitive exchange of reducing equivalents between cytoplasmic and mitochondrial compartments involving an increased mitochondrial glycerol phosphate dehydrogenase activity has been proposed to account for the Ca2+-dependent increase in gluconeogenesis from reduced substrates such as glycerol and sorbitol in hepatocytes prepared from 24h-starved rats (Kneer et al., 1979; Yip & Lardy, 1981) . Concentrations of amino-oxyacetate that block the malate-aspartate shuttle reportedly had no effect on noradrenaline-induced glucose output from these relatively reduced substrates (Kneer et al., 1979) .
Some of the findings reported by Kneer et al. (1979) and Yip & Lardy (1981) differ substantially from the data obtained with perfused livers as documented in the present study. The different results obtained may in part reflect differences between the hepatocytes and perfused liver preparations used, as well as differences in the time of a-agonist treatment and the techniques employed to deplete the relevant Ca2+ pool(s). In this regard, it is Vol. 212 noteworthy that hepatocyte preparations have previously been reported to become depleted of malate and aspartate, and consequently exhibit low malate-aspartate-shuttle activities (Cederbaum et al., 1977) . In addition, in relatively long-term experiments such as those of Kneer et al. (1979) , inhibition of reducing-equivalent transfer by amino-oxyacetate may be by-passed as glycerol phosphate concentrations rise and flux through the mitochondrial glycerophosphate dehydrogenase increases (Williamson et al., 1971) .
In our hands amino-oxyacetate significantly decreased basal glucose output from sorbitol and glycerol and effectively blocked the phenylephrineinduced increases in glucose output observed with these reduced substrates. Data in the present study then indicate that a-adrenergic agonists may increase gluconeogenesis from glycerol and sorbitol by promoting the removal of cytoplasmic reducing equivalents by the operation of the malate-aspartate shuttle, although some involvement of the glycerol phosphate-dihydroxyacetone phosphate shuttle cannot be ruled out. The mechanism whereby a-agonists may stimulate the malate-aspartate shuttle is unknown, but may be related either to changes in total amounts of shuttle intermediates or to a change in the energization of the mitochondrial inner membrane, which may in turn affect the electrogenic exchange of aspartate for glutamate.
Other data presented are consistent with the suggestion that glucose output from glycerol and sorbitol may be enhanced by an increase in the rate of oxidation of cytoplasmic nicotinamide nucleotides. The electron acceptor phenazine methosulphate, and to a lesser extent dinitrophenol, an uncoupler of oxidative phosphorylation, enhanced glucose output from both of these reduced substrates. In addition, phenylephrine-induced increases tricarboxylic acid-cycle flux. We also observed a 40-50% increase in total ketone-body output. Sugden et al. (1980) have reported the stimulation of conversion of [1-14CIoleate into "4CO2 in rat hepatocytes after administration of adrenaline or vasopressin. Data from the present study and that of Sugden et al. (1980) suggest that a-agonists may increase the mitochondrial redox ratio mainly as a result of an increased rate of fl-oxidation of fatty acids and an increased flux through the tricarboxylic acid cycle. A (McCormack & Denton, 1981) , and a -Ca2+-dependent inhibition of acetyl-CoA carboxylase has been observed in hepatocytes treated with a-adrenergic agonists (Ly & Kim, 1981) , it is not known if these effects are involved in the stimulation of tricarboxylic acid-cycle flux and ketogenesis described in the present study.
We also report the Ca2+-dependent activation by a-adrenergic agonists of glucose output from fructose and dihydroxyacetone, substrates which enter the gluconeogenic pathway at the triose phosphate level. Since these changes were observed in the absence of significant changes in glycolysis (lactate +pyruvate output unchanged), a-adrenergic agonists may stimulate the gluconeogenic pathway at other site(s) located between the triose phosphates and glucose. A Ca2+-dependent inhibition of fructose 6-phosphate 2-kinase, and lowered concentration of the activator of phosphofructokinase, fructose 2,6-bisphosphate, have been described in hepatocytes after treatment with adrenaline (Richards & Uyeda, 1982) . Thus a-agonists may also inhibit phosphofructokinase and decrease the rate of cycling of fructose phosphates. However, such a proposed action may be limited in the starved state, as phosphofructokinase activity and the cycling of fructose phosphate are already extremely low in starved-rat liver (Kummel, 1982; Van Schaftingen et al., 1980) . Consequently, a future study should examine the possibility that a-adrenergic agonists may stimulate fructose 1 ,6-bisphosphatase or glucose 6-phosphatase activities.
